tldrdaily.news logo

FDA Enhances Transparency by Publishing Over 200 Rejection Letters to Drugmakers

1 min read
Source: fda.gov
FDA Enhances Transparency by Publishing Over 200 Rejection Letters to Drugmakers
Photo: fda.gov
TL;DR Summary

The FDA has begun publishing over 200 complete response letters (CRLs) issued between 2020 and 2024 to increase transparency and provide the public with insights into its decision-making process regarding drug and biological product approvals, aiming to improve predictability and reduce repeated mistakes in drug development.

Topics:business#crls#drug-approval#fda#health#public-access#transparency
Share this article
  1. FDA Embraces Radical Transparency by Publishing Complete Response Letters  fda.gov
  2. FDA to Share Rejection Letters Drugmakers Often Keep Secret  Bloomberg.com
  3. FDA publishes rejection letters sent to drugmakers, with a big caveat  STAT
  4. FDA publishes over 200 complete response letters (MRK:NYSE)  Seeking Alpha
  5. US FDA publishes 200 rejection letters in transparency push  Reuters

Reading Insights

Total Reads

0

Unique Readers

8

Time Saved

2 min

vs 3 min read

Condensed

89%

437 → 46 words

Want the full story? Read the original article

Read on fda.gov